Reproductive Endocrinology
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Krystallenia I Alexandraki, Eleni A Kandaraki, Kalliopi-Anna Poulia
Polycystic ovary syndrome (PCOS) is a heterogeneous syndrome, considered the most common endocrinopathy in women of reproductive age, with a prevalence of 6–8% in premenopausal women.1,2 However, long-term sequelae are extended beyond the reproductive axis, being present from birth to senescence. Consequently, early detection and treatment options are in high demand to prevent long-term complications. This […]